Previous 10 | Next 10 |
Blueprint Medicines ([[BPMC]] -1.1%) promoted Andy Boral, M.D., Ph.D. to EVP, Clinical Development from his current chief medical officer position.Becker Hewes, M.D. will be named chief medical officer.Marion Dorsch, Ph.D., Chief Scientific Officer, has resigned from the company, ef...
Blueprint Medicines Announces R&D Leadership Transitions Blueprint Medicines Announces R&D Leadership Transitions -- Becker Hewes, M.D., promoted to Chief Medical Officer -- -- Andy Boral, M.D., Ph.D., to transition from Chief Medical Officer to Executive Vice Pr...
Blueprint Medicines Reports Portfolio Milestones and Outlines 2021 Roadmap for Precision Medicine Leadership -- AYVAKIT™ (avapritinib) granted FDA breakthrough therapy designation for the treatment of moderate to severe indolent systemic mastocytosis -- -- Positive to...
Cogent Biosciences (COGT) is up +3.8% after Piper Sandler initiated the coverage with an overweight rating on the stock. The price target at $22 per share is +80.3% to yesterday’s close.Noting that the ‘risk/reward now meaningfully skews to the upside after the company...
Blueprint Medicines (BPMC) has submitted a supplemental new drug application to the FDA seeking approval for Ayvakit (avapritinib) for the treatment of adult patients with advanced systemic mastocytosis ((SM)), a rare disorder characterized by the uncontrolled proliferation and activation of ...
Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanced Systemic Mastocytosis CAMBRIDGE, Mass. , Dec. 17, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision th...
Halvorsen's 13F portfolio value increased from $23.14B to $27.68B. The number of positions increased 71 to 86. Viking Global increased Microsoft, Mecadolibre, and CME Group while reducing Amazon.com and dropping Uber Technologies & JD.com. The top three positions are Microsoft...
Blueprint Medicines Data Presented at 62nd ASH Annual Meeting and Exposition Highlight Broad Commitment to Advance Patient Care in Systemic Mastocytosis CAMBRIDGE, Mass. , Dec. 7, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision thera...
Blueprint Medicines ([[BPMC]] -2.5%) and collaboration partner Roche ([[RHHBY]] +2.1%) announce the FDA nod for Gavreto (pralsetinib) for the treatment of advanced/metastatic RET fusion-positive medullary thyroid cancer in patients at least 12 years old who require systemic therapy and who ar...
Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer CAMBRIDGE, Mass. , Dec. 1, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (N...
News, Short Squeeze, Breakout and More Instantly...
Blueprint Medicines Corporation Company Name:
BPMC Stock Symbol:
NASDAQ Market:
Blueprint Medicines Corporation Website:
Blueprint Medicines to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 PR Newswire CAMBRIDGE, Mass. , July 18, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call an...
2024-07-10 04:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 12.5% to $0.27 on volume of 477,193,667 shares NVIDIA Corporation (NVDA) rose 1.9% to $128.2 on volume of 232,119,115 shares Virpax Pharmaceuticals Inc. (VRPX) rose 92.0% to $1.11 on volume o...